Printer Friendly

Molecular Response Names Scientific Advisory Board Members.

SAN DIEGO -- Molecular Response (MRL), a privately held molecular diagnostic services company and a leader in the identification of target populations for high value therapeutics, announced today the appointment of leading experts to its Scientific Advisory Board.

The members of the new advisory team represent a combination of scientific and medical expertise in oncology and genomic medicine that will support the company as it expands its focus on precision medicine.

"Molecular Response is proud to have assembled such a prestigious and highly experienced team," said Molecular Response CSO, Tommy Broudy, PhD. "Their selection to our advisory group solidifies our commitment to bridging the gap between cutting edge research and actionable clinical information to treat patients."

The Scientific Advisory Board members include: Samuel Levy, PhD, Director of Genomic Sciences at Scripps Translational Science Institute and Scripps Genomic Medicine, and Professor of Molecular and Experimental Medicine at the Scripps Research Institute; Patrick M. O'Connor, PhD, Founder and Chief Scientific Officer of Selexagen Therapeutics, Inc. and Senior Editor of the journal Cancer Research; and Art Mendoza MD, Chief of Pathology at Sharp Memorial Hospital and Director of Pathology at Mary Birch Hospital for Women, Sharp Healthcare.

About Molecular Response

Molecular Response is a leader in advancing targeted therapeutics through intelligently designed, clinically validated companion diagnostics. Our goal is to reduce risk and cost of therapeutic drug development for our partners by translating clinically relevant molecular response marker data into high-value knowledge while fully integrated into existing pharmaceutical development processes and programs. Our results reduce risk and cost of drug development and allow for the most informed decisions with best chance of success to advance therapeutic programs.

For additional information please visit www.molecularresponse.com.

For detailed biographies of the SAB members please choose from following links:

Samuel Levy, PhD

Patrick M. O'Connor, PhD

Art Mendoza, MD
COPYRIGHT 2011 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2011 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1U9CA
Date:May 9, 2011
Words:359
Previous Article:Lithium Corporation Receives Salt Wells Drill Permit Approval.
Next Article:University of New Hampshire InterOperability Laboratory Partners with Spirent to Test Network Protection Devices.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters